Etienne-Grimaldi et al. examined the effect of FCGR2A H131R and FCGR3A V158F SNPs on the efficacy of cetuximab in metastatic colorectal cancer patients treated with cetuximab and irinotecan in combination with oral tegafur-uracil [41]. Here, FCGR3A is linked to metastatic colorectal cancer.